curious as to why no news about Ambs or presentati
Post# of 30027
General search about conference reveals saturated coverage regarding NeuroPhage a private company targeting misfolded proteins...interesting that similar areas of interest as ambs and a very strong PR strategy. comments anyone as to the disconnect.